Robert Califf has industry connections, just like during his previous confirmation to lead the US FDA, but they are different now, as he holds several board seats in addition to a full-time position at a health care tech company.

Robert Califf has industry connections, just like during his previous confirmation to lead the US FDA, but they are different now, as he holds several board seats in addition to a full-time position at a health care tech company.

US FDA commissioner-nominee Califf calls for streamlining clinical trial bureaucracy, as well as open access to clinical data.

Janssen’s Troy Sarich outlines why it’s hard to emulate randomized controlled trials with real-world evidence studies, emphasizing that the two are “not in competition.” He also highlights the huge strides made by AI-driven technology firms to provide “research-ready” structured data and new game-changing advances in the area of health sensors.